So not much of an outcome then...
If Mary-Beth couldn’t crack a medtech/health sector/ADHD pharma partnership while incentivised to, and hailing from that sector, then there is not much expectation now for further progress imo.
This is basically now just a ghost company.
Add to My Watchlist
What is My Watchlist?